Ten-Year Breast Cancer Survival Improved In Past 60 Years, MD Anderson Study Finds
Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival
Racial Disparities Remain In Breast Cancer Care
DCIS With Higher Density May Increase Risk For Disease
Choice Of Reconstruction Can Depend On Who Consults
Only 20% of Doctors Advise CRC According To Guidelines
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
